InnoCare Pharma (SHA:688428, HKG:9969) approved the vesting of shares under a stock incentive plan and the cancellation of granted but unvested shares, according to a Tuesday filing with the Shanghai bourse.
The company will vest more than 2.4 million restricted shares granted to 74 recipients.
InnoCare will cancel 157,000 shares that are granted but unvested, as the four recipients have departed InnoCare, and cancel 167,000 restricted shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments